Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000000 participants
OBSERVATIONAL
2014-07-31
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The specific objectives of the project are to:
1. identify subjects at high-risk of CVD and provide counseling for medication and lifestyle improvements
2. evaluate the feasibility of such screening methods for subjects at high risk of CVD, and to assess the effect of health counseling on CVD incidence rates and risk factors control
3. inform future intervention and long-term follow up efforts for primary and secondary CVD prevention in China.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peking University & University of Michigan Study of MI and Atherosclerosis
NCT04950699
Beijing Vascular Disease Patients Evaluation STudy
NCT02569268
Precursors of CVD Risk Factors--Project Heartbeat
NCT00005478
A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population
NCT04958629
Epidemiological and Genetic Studies of Body Mass Index
NCT00035698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. registered in the Hukou of the selected region
3. sign the consent form
Exclusion Criteria
35 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China National Center for Cardiovascular Diseases
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lixin Jiang, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
China National Center for Cardiovascular Diseases
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fuwai hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Wang Y, Peng K, Xu W, Huang X, Liu X, Li Y, Lu J, Yang Y, Chen B, Shi Y, Han G, Zhang X, Cui J, Song L, Tian A, Runsi W, Wang C, Tian Y, Wu Y, Lin C, Peng W, Li X, Hu S. Cardiovascular disease-specific and all-cause mortality across socioeconomic status and lifestyles among patients with established cardiovascular disease in communities of China: data from a national population-based cohort. Heart. 2025 Mar 13:heartjnl-2024-324766. doi: 10.1136/heartjnl-2024-324766. Online ahead of print.
Wang R, Wang Y, Lu J, Li Y, Wu C, Yang Y, Cui J, Xu W, Song L, Yang H, He W, Zhang Y, Zhang X, Li X, Hu S. Forecasting cardiovascular disease risk and burden in China from 2020 to 2030: a simulation study based on a nationwide cohort. Heart. 2025 Feb 12;111(5):205-211. doi: 10.1136/heartjnl-2024-324650.
China PEACE Collaborative Group; Zhou T, Wang Y, Zhang H, Wu C, Tian N, Cui J, Bai X, Yang Y, Zhang X, Lu Y, Spatz ES, Ross JS, Krumholz HM, Lu J, Li X, Hu S. Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional study. Lancet Glob Health. 2023 Jan;11(1):e83-e94. doi: 10.1016/S2214-109X(22)00428-4.
Lu J, Xuan S, Downing NS, Wu C, Li L, Krumholz HM, Jiang L. Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot. BMJ Open. 2016 Jan 4;6(1):e010200. doi: 10.1136/bmjopen-2015-010200.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20150823
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.